Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases

被引：0

作者：

Ichinose, Kunihiro ^{[1
]}

Origuchi, Tomoki ^{[2
]}

Kawashiri, Shin-ya ^{[1
]}

Iwamoto, Naoki ^{[1
]}

Fujikawa, Keita ^{[1
]}

Aramaki, Toshiyuki ^{[1
]}

Kamachi, Makoto ^{[1
]}

Arima, Kazuhiko ^{[1
]}

Tamai, Mami ^{[1
]}

Nakamura, Hideki ^{[1
]}

Ida, Hiroaki ^{[1
]}

Kawakami, Atsushi ^{[1
]}

Eguchi, Katsumi ^{[1
]}

机构：

[1] Nagasaki Univ, Dept Rheumatol, Unit Translat Med, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Dept Phys Therapy, Unit Rehabil, Grad Sch Biomed Sci, Nagasaki 8528501, Japan

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 02期

关键词：

Rheumatoid arthritis (RA); Adalimumab; Long-term; DAS28-CRP; ANTITUMOR NECROSIS FACTOR; MONOCLONAL-ANTIBODY; METHOTREXATE; RISK; TUBERCULOSIS; EFFICACY; THERAPY; DISEASE; SAFETY;

D O I：

10.1007/s00296-010-1770-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We present six cases of patients with Japanese rheumatoid arthritis (RA) treated with a tumor necrosis factor (TNF)-alpha blocking agent, adalimumab as monotherapy for 220 weeks. All six patients were women, and the median age was 54.0 +/- A 7.07 years old. The median duration of the disease was 7.43 +/- A 11.1 years, and the median disease activity score (DAS28-CRP) was 5.35 +/- A 0.69. Three of six patients were able to continue to receive this treatment for 220 weeks successfully, and the DAS28-CRP decreased to 1.89 +/- A 0.75. Two patients withdrew because of lack of efficacy, and one patient withdrew because of adverse events (non-Hodgkin lymphoma). Adalimumab resulted in a sustained clinical response in RA patients during 220-week follow-up.

引用

页码：483 / 487

页数：5

共 50 条

[1] Long-term follow-up of adalimumab monotherapy for rheumatoid arthritis in Japanese patients: a report of six cases
Kunihiro Ichinose
Tomoki Origuchi
Shin-ya Kawashiri
Naoki Iwamoto
Keita Fujikawa
Toshiyuki Aramaki
Makoto Kamachi
Kazuhiko Arima
Mami Tamai
Hideki Nakamura
Hiroaki Ida
Atsushi Kawakami
Katsumi Eguchi
Rheumatology International, 2012, 32 : 483 - 487
[2] JUVENILE RHEUMATOID ARTHRITIS - A LONG-TERM FOLLOW-UP
BARKIN, RE
ANNALS OF THE RHEUMATIC DISEASES, 1952, 11 (04) : 316 - 317
[3] Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: A prospective long-term follow-up
Atzeni, Fabiola
Doria, Andrea
Ghirardello, Anna
Villalta, Danilo
Zampieri, Sandra
Carrabba, Mario
Sarzi-Puttini, Piercarlo
AUTOIMMUNITY, 2008, 41 (01) : 87 - 91
[4] COMBINATION VS MONOTHERAPY FOR POOR PROGNOSIS RHEUMATOID ARTHRITIS: A LONG-TERM FOLLOW-UP STUDY
Bejarano, V.
Philip, C.
Michael, G.
Heather, K.
Paul, E.
RHEUMATOLOGY, 2004, 43 : 45 - 45
[5] LONG-TERM FOLLOW-UP OF PATIENTS WITH RHEUMATOID ARTHRITIS: EMPHASIS ON VERTEBRAL DEFORMATIONS
Kovalenko, P.
Dydykina, I.
Smirnov, A.
Glukhova, S.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S500 - S500
[6] EROSION COUNT DYNAMICS IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH LONG-TERM FOLLOW-UP
Kovalenko, P.
Dydykina, I.
Smirnov, A.
Diatroptov, M.
Glukhova, S.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S500 - S500
[7] Intraventricular craniopharyngioma: a long-term follow-up of six cases
Davies, MJ
King, TT
Metcalfe, KA
Monson, JP
BRITISH JOURNAL OF NEUROSURGERY, 1997, 11 (06) : 533 - 541
[8] Combination vs monotherapy for poor prognosis rheumatoid arthritis: A long-term follow-up study.
Bejarano, V
Conaghan, P
Green, M
King, H
Emery, P
ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S125 - S125
[9] A long-term follow-up of zonisamide monotherapy
Fukushima, Katsuyuki
Seino, Masakazu
EPILEPSIA, 2006, 47 (11) : 1860 - 1864
[10] LONG-TERM FOLLOW-UP OF PATIENTS WITH RHEUMATOID ARTHRITIS: EMPHASIS ON BONE MINERAL DENSITY
Kovalenko, P.
Dydykina, I.
Smirnov, A.
Glukhova, S.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S499 - S500

← 1 2 3 4 5 →